More than 30,000 healthcare professionals from over 150 countries are set to gather in Munich, Germany, for this year’s ESC Congress.
Established as the world’s premier conference on the science, management and prevention of cardiovascular disease, the congress attracts cardiologists, cardiovascular surgeons, nurses, primary care physicians, scientists, technicians, medical students, healthcare industry leaders, regulators and others active in the field.
It will be held from 25-29 August 2012 at the Messe München.
The spotlight of the 2012 congress is “From Bench to Practice”. The theme will be explored in various types of sessions and foster critical discussion of how new techniques can be rapidly translated into clinical medicine.
“The spotlight was chosen because we have many innovations which have to be transferred into clinical practice,” says Professor Michael Böhm, Chairperson of the ESC Congress Programme Committee.
As in previous years, the scientific programme will highlight the most relevant issues in the diagnosis, management and treatment of cardiovascular disease, ranging from basic to clinical and population research.
This year promises exciting clinical trial results and greater interaction during the sessions. For the first time clinical trials and registries on a particular subject will be presented in one update session.
These sessions will bring the latest results in cardiovascular medicine to the public arena and be a rich source of news stories. Back by popular demand, the 2012 congress will again feature two types of focus sessions.
FOCUS Imaging Intervention sessions will provide real time satellite transmission of live interventions conducted at hospitals in Europe.
During FOCUS Cardiology Practice sessions an international panel of experts will discuss a clinical case and the audience will vote on how they would treat the case.
Around 200 exhibitors from the pharmaceutical, equipment and device industries will display their cardiovascular products and services.
The ESC Congress is an international congress organised by Europeans.
The programme will feature 29 joint sessions with international sister societies, and the ESC’s 54 National Cardiac Societies and 34 Affiliated Cardiac Societies will be invited to send delegates and organise exhibits.
“It is the leading cardiovascular forum in the world, given the size of attendance and the number of scientific sessions,” says Professor Michel Komajda, President of the ESC.
“The meeting is very international and the quality of presentations is excellent.
“The spotlight topic, From Bench to Practice, will focus on the fact that in life sciences it is very important to translate the results and progress made in the lab and apply this to clinical practice for the benefit of patients.”